Bottom line
What does FTXH hold?
FTXH held 51 positions as of Jun 30, 2026. Its largest holding is Eli Lilly & Company at 7.77% of the fund, and the top 10 positions add up to 53.1%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Aug 21, 2026
FTXH top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Company LLY ELI LILLY & COMPANY COM |
Stocks | 7.77% | $2.8M |
| 2 | Abbvie Inc ABBV ABBVIE INC COM |
Stocks | 7.39% | $2.7M |
| 3 | Merck & Company Inc MRK MERCK & COMPANY INC COM |
Stocks | 7.07% | $2.6M |
| 4 | Johnson & Johnson JNJ JOHNSON & JOHNSON COM |
Stocks | 6.96% | $2.5M |
| 5 | Bristol-myers Squibb Company BMY BRISTOL-MYERS SQUIBB COMPANY COM |
Stocks | 6.29% | $2.3M |
| 6 | Biogen Inc BIIB BIOGEN INC COM |
Stocks | 3.84% | $1.4M |
| 7 | Viatris Inc VTRS VIATRIS INC COM |
Stocks | 3.62% | $1.3M |
| 8 | Cardinal Health Inc CAH CARDINAL HEALTH INC COM |
Stocks | 3.53% | $1.3M |
| 9 | Vertex Pharmaceuticals Inc VRTX VERTEX PHARMACEUTICALS INC COM |
Stocks | 3.41% | $1.2M |
| 10 | Amgen Inc AMGN AMGEN INC COM |
Stocks | 3.18% | $1.2M |
| 11 | Pfizer Inc PFE PFIZER INC COM |
Stocks | 2.97% | $1.1M |
| 12 | Gilead Sciences Inc GILD GILEAD SCIENCES INC COM |
Stocks | 2.89% | $1.0M |
| 13 | United Therapeutics Corp UTHR UNITED THERAPEUTICS CORP COM |
Stocks | 2.72% | $987.2K |
| 14 | Regeneron Pharmaceuticals Inc REGN REGENERON PHARMACEUTICALS INC COM |
Stocks | 2.72% | $984.6K |
| 15 | Jazz Pharmaceuticals Plc JAZZ JAZZ PHARMACEUTICALS PLC SHS USD |
Stocks | 2.49% | $901.5K |
| 16 | Incyte Corp INCY INCYTE CORP COM |
Stocks | 2.39% | $867.0K |
| 17 | Illumina Inc ILMN ILLUMINA INC COM |
Stocks | 1.98% | $718.8K |
| 18 | Zoetis Inc ZTS ZOETIS INC CL A |
Stocks | 1.87% | $676.7K |
| 19 | Exelixis Inc EXEL EXELIXIS INC COM |
Stocks | 1.72% | $625.1K |
| 20 | Charles River Laboratories International Inc CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC COM |
Stocks | 1.49% | $539.1K |
| 21 | Medpace Holdings Inc MEDP MEDPACE HOLDINGS INC COM |
Stocks | 1.41% | $511.6K |
| 22 | Ptc Therapeutics Inc PTCT PTC THERAPEUTICS INC COM |
Stocks | 1.37% | $496.8K |
| 23 | Neurocrine Biosciences Inc NBIX NEUROCRINE BIOSCIENCES INC COM |
Stocks | 1.37% | $495.3K |
| 24 | Alkermes Plc ALKS ALKERMES PLC SHS |
Stocks | 1.35% | $490.7K |
| 25 | Halozyme Therapeutics Inc HALO HALOZYME THERAPEUTICS INC COM |
Stocks | 1.21% | $437.8K |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 21, 2026